American Gene Technologies, a Rockville-based biotech firm, announced on Friday that it was standing up a new company to oversee its HIV treatment project, which recently completed Phase 1 of its clinical trial. "When we did the efficacy part of the Phase 1 trial, we got really encouraging data that makes us believe that we're on track for a potential solution for people that are living with HIV to return them to a normal life with a one-and-done treatment," AGT's founder and CEO Jeff Galvin...
